Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Net Current Assets

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹3,328 Cr₹1,609 Cr₹3,877 Cr₹3,593 Cr₹3,159 Cr

What is the latest Net Current Assets ratio of GLENMARK PHARMACEUTICALS ?

The latest Net Current Assets ratio of GLENMARK PHARMACEUTICALS is ₹3,328 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹3,328 Cr
Mar2024₹1,609 Cr
Mar2023₹3,877 Cr
Mar2022₹3,593 Cr
Mar2021₹3,159 Cr

How is Net Current Assets of GLENMARK PHARMACEUTICALS Trending?

Years Net Current Assets % Change
Mar2025 ₹3,328 Cr
106.80
Mar2024 ₹1,609 Cr
-58.49
Mar2023 ₹3,877 Cr
7.92
Mar2022 ₹3,593 Cr
13.75
Mar2021 ₹3,159 Cr -

Compare Net Current Assets of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹64,793.1 Cr 5% 1% 7.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹468,530.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹219,675.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,970.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹117,947.0 Cr 0.2% 2.1% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹96,601.2 Cr 0.2% -7.7% -7.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

5%

1%

7.8%

SENSEX

-0.1%

2.4%

-3.3%


You may also like the below Video Courses